Back to top
more

Orthofix Medical (OFIX)

(Delayed Data from NSDQ)

$9.70 USD

9.70
221,253

+0.07 (0.73%)

Updated Aug 28, 2026 04:00 PM ET

After-Market: $9.71 +0.01 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 248)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Orthofix (OFIX) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Orthofix (OFIX) delivered earnings and revenue surprises of +66.67% and +2.65%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

FMS vs. OFIX: Which Stock Is the Better Value Option?

by Zacks Equity Research

FMS vs. OFIX: Which Stock Is the Better Value Option?

Zacks Equity Research

ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7

by Zacks Equity Research

Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.

Zacks Equity Research

FMS vs. OFIX: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

FMS vs. OFIX: Which Stock Is the Better Value Option?

Zacks Equity Research

Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Orthofix (OFIX) delivered earnings and revenue surprises of +225.00% and +3.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Idexx (IDXX) delivered earnings and revenue surprises of +9.67% and +4.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Orthofix (OFIX) delivered earnings and revenue surprises of 52.94% and 1.87%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 5.85% and 3.27%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Globus Medical Expands Anterior Spine Portfolio With Two New Offerings

by Zacks Equity Research

GMED announces the commercial launch of COHERE ALIF Spacer and Modulus ALIF Blades.

Zacks Equity Research

Orthofix (OFIX) Q4 Earnings Lag Estimates

by Zacks Equity Research

Orthofix (OFIX) delivered earnings and revenue surprises of -66.67% and 1.53%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?